| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | CELGENE CORP | 525,000 | 60,522,000 | 34.44% | Put | |
| 2 | QUOTIENT LTD | 1,123,641 | 19,102,000 | 10.87% | ||
| 3 | PFENEX INC COM | 653,393 | 10,415,000 | 5.93% | ||
| 4 | MERCK & CO INC | 145,000 | 8,335,000 | 4.74% | ||
| 5 | LILLY ELI & CO | 100,000 | 7,265,000 | 4.13% | Put | |
| 6 | ASTRAZENECA PLC | 100,000 | 6,843,000 | 3.89% | Put | |
| 7 | UNITED THERAPEUTICS | 34,700 | 5,983,000 | 3.40% | ||
| 8 | CARDINAL HEALTH INC | 58,000 | 5,236,000 | 2.98% | ||
| 9 | JOHNSON & JOHNSON | 50,000 | 5,030,000 | 2.86% | Put | |
| 10 | ADAMIS PHARMACEUTICALS CORP | 1,179,981 | 4,649,000 | 2.65% | ||
| 11 | JOHNSON & JOHNSON | 45,000 | 4,527,000 | 2.58% | ||
| 12 | ADDUS HOMECARE CORP COM | 189,466 | 4,362,000 | 2.48% | ||
| 13 | CERNER CORP | 53,800 | 3,941,000 | 2.24% | Put | |
| 14 | ABBVIE INC | 55,000 | 3,220,000 | 1.83% | ||
| 15 | UNITEDHEALTH GROUP INC | 26,500 | 3,135,000 | 1.78% | ||
| 16 | ARATANA THERAPEUTICS INC COM | 178,550 | 2,859,000 | 1.63% | ||
| 17 | CELLADON CORP | 138,800 | 2,629,000 | 1.50% | Put | |
| 18 | TRIPLE S MGMT CORP CL B | 112,400 | 2,235,000 | 1.27% | ||
| 19 | STEMLINE THERAPEUTICS INC | 140,000 | 2,026,000 | 1.15% | ||
| 20 | HERON THERAPEUTICS INC | 137,100 | 1,995,000 | 1.14% | ||
| 21 | FORWARD PHARMA A/S | 67,455 | 1,910,000 | 1.09% | ||
| 22 | Agile Therapeutics, Inc. | 203,732 | 1,889,000 | 1.07% | ||
| 23 | HARVARD APPARATUS REGENER TE | 455,901 | 1,482,000 | 0.84% | ||
| 24 | MIRATI THERAPEUTICS INC COM | 46,677 | 1,369,000 | 0.78% | ||
| 25 | SCYNEXIS INC | 152,780 | 1,268,000 | 0.72% | ||
| 26 | TG THERAPEUTICS INC COM | 76,924 | 1,191,000 | 0.68% | ||
| 27 | TOKAI PHARMACEUTICALS INC | 82,283 | 930,000 | 0.53% | ||
| 28 | INSPIREMD INC | 2,227,562 | 713,000 | 0.41% | ||
| 29 | MERIT MED SYS INC COM | 24,235 | 467,000 | 0.27% | ||
| 30 | BioDelivery Sciences International Inc | 169,200 | 201,000 | 0.11% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001214659-15-004036, filed 2015.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
